Nurexa Pharma Private Limited
About Nurexa Pharma Private Limited
Data last updated:
Nurexa Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 27 July 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1995PTC091080. Its GSTIN is 27AAACZ0155E2ZK (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2.45 Lakh. It was formerly known as Zydus Trading Company Private Limited. It is led by directors including Sameer Ashok Paigankar and Suneela Ashok Paigankar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.47 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹3.19 Cr (net margin 33.6%) and EBITDA of ₹4.18 Cr (EBITDA margin 44.1%). Revenue has grown at a compounded annual rate (CAGR) of 64% over three years and 111% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Nurexa Pharma has one previous CIN (Corporate Identification Number): U24230MH2004PTC091080. The current CIN is U24230MH1995PTC091080, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH1995PTC091080 | Current |
| U24230MH2004PTC091080 | Previous |
Contact details
Nurexa Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address3801 38th Floor A Wing T 5, Lodha Kiara Pandurang Budkar Marg Worli Lower Parel, Mumbai, Maharashtra, India – 400013
- IndustryBusiness Outsourcing, Business & IT Consulting
To see the full contact details of Nurexa Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nurexa Pharma is professional, scientific and technical activities. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 74 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Nurexa Pharma Private Limited, buy the company report.
Financials of Nurexa Pharma Private Limited
FY 2025 filings availableNurexa Pharma Private Limited reported revenue of ₹9.47 Cr (up 249% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 111% over five years, including 249% growth in the latest year. EBITDA rose 79% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.18 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.19 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 44.1% | ||||
| Net Profit Margin | 33.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nurexa Pharma Private Limited, buy the company report.
Board of directors of Nurexa Pharma Private Limited
Nurexa Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sameer Ashok Paigankar Also directs: My Healthskape Medicals Private Limited, Nutragenix Healthcare Private Limited, Hemani Industries Limited and 4 more | Director | 16 May 2013 | 13 Years 5 Months | Current |
| Suneela Ashok Paigankar | Director | 27 Jul 1995 | 31 Years 2 Months | Current |
| Sheela Sameer Paigankar | Director | 28 Sep 1996 | 30 Years 0 Months | Current |
Auditor
Nurexa Pharma Private Limited is audited by PHD & Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PHD & Associates | FY 2022 | 111236W |
Shareholding
The shareholding of Nurexa Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nurexa Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nurexa Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Nurexa Pharma Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 2 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Makarand M. Joshi & Co. |
To see the full MSME payment records of Nurexa Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Nurexa Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACZ0155E2ZK | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nurexa Pharma Private Limited, buy the company report.
Recent activity
Nurexa Pharma Private Limited has 3 board changes on record since 1995: 3 appointments. The latest: Sameer Ashok Paigankar was appointed as Director on 16 May 2013.
Frequently asked questions
Nurexa Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in business and IT consulting, within the business outsourcing industry. It was incorporated on 27 July 1995 (31+ years old) and is registered under CIN U24230MH1995PTC091080.
Nurexa Pharma has 3 current directors:
- Sameer Ashok Paigankar - Director
- Suneela Ashok Paigankar - Director
- Sheela Sameer Paigankar - Director
The latest financial statements of Nurexa Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nurexa Pharma is 27AAACZ0155E2ZK, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Nurexa Pharma is U24230MH1995PTC091080. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nurexa Pharma was incorporated on 27 July 1995, making it 31+ years old. It is registered with the Registrar of Companies, Mumbai.
Sameer Ashok Paigankar was appointed as Director on 16 May 2013. Sheela Sameer Paigankar was appointed as Director on 28 Sep 1996. Suneela Ashok Paigankar was appointed as Director on 27 Jul 1995.
Nurexa Pharma has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 2 overdue payments to 1 micro and small supplier. The latest return was filed on 08 Jun 2019.
The registered office of Nurexa Pharma is at 3801 38th Floor A Wing T 5, Lodha Kiara Pandurang Budkar Marg Worli Lower Parel, Mumbai, Maharashtra, India – 400013.
Nurexa Pharma operates in the business outsourcing industry, in the business and IT consulting segment.
The compliance status of Nurexa Pharma is compliant as of 08 September 2026. The company is actively filing with the Registrar of Companies.